Overview
HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
Status:
Recruiting
Recruiting
Trial end date:
2025-08-01
2025-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This pragmatic randomized trial is designed to evaluate the relative vaccine effectiveness of QIV-HD vs. QIV-SD in reducing the risk of hospitalization for influenza or pneumonia in adults 65-79 years of age in Galicia during 2023/2024 and 2024/2025 seasons.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Federico Martinón Torres
Criteria
Inclusion Criteria:- 1. Age 65-79 years residing in the community (only individuals who are not eligible to
receive QIV-HD as part of the standard of care)
- 2. Informed consent form has been signed and dated
Exclusion Criteria:
- There are no specific exclusion criteria for this study